The relationship between glycated hemoglobin A1c levels and exacerbation status in the patients with chronic obstructive pulmonary disease

Table 2 HbA1c status in patients with COPD base on the intensity of air flow restriction in the GOLD; FEV1, MMRC (n = 112)

	Categories	Number of patients	HbA1c Mean (rang)	p-value
The intensity of air flow restriction in the GOLD	A	6	^a5.05 (4.90-6.00)*	0.001**
	B	18	^a5.25 (4.90-7.00)*
	C	6	^ab5.35 (5.10–6.20)*
	D	82	^b5.96 (4.90–8.10)*
Severity of COPD base on FEV1	Mild	9	*(6.20–4.90) 5.10	0.076**
	Moderate	60	*(7.20–4.90) 5.90
	Severe	35	*(8.10–4.90) 5.90
	Very severe	8	*(7.20–5.20) 5.90
Frequency of exacerbation (Year)	None	31	*(00.7–90.4) 50.5 ^a	0.022**
	Once	49	*(10.8–90.4) 10.6 ^b
	Twice and more	32	*(20.7–90.4) 85.5 ^ab
The Modified Medical Research Council (MMRC)	1	10	*(20.6–90.4)10.5^a	0.007**
	2	35	(20.7–90.4) 80.5 ^ab
	3	47	(10.8–90.4) 10.6 ^b
	4	20	(10.7–90.4) 75.5 ^ab

*Identical lowercase letters indicate no statistically significant difference in the Mann-Whitney comparative test with Bonferroni correction (p > 0.017)
**Kruskal Wallis Test
Glycated hemoglobin (HbA1c); Global Initiative for Chronic Obstructive Lung Disease (GOLD); forced expiratory volume in one second (FEV1), Modified Medical Research Council (MMRC) (n = 112)

ISSN: 1756-0500